No Data
No Data
No Data
AI drug developer 'English Silicon asia vets', may list in Hong Kong, IPO team includes CICC, morgan stanley
According to sources, AI drug developer Insilico Medicine plans to list in Hong Kong and has appointed China International Capital Corporation and Morgan Stanley to facilitate the process, expecting to raise approximately $0.2 billion.
Intrinsic Medicine and Phoenix Biotech Acquisition Corp. Mutually Agree to Terminate Business Combination Agreement
Phoenix Biotech to Take Intrinsic Medicine Public in SPAC Deal
Press Release: Intrinsic Medicine and Phoenix -2-
Intrinsic Medicine Files to Withdraw Planned IPO
Intrinsic Medicine Withdraws IPO Filing
Unlock the Full List